Trial Profile
Assessment of the Hydraulic Tissue Resistance at the Site of Subcutaneous Insulin Infusion in Patients with Type 1 Diabetes
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Apr 2022
Price :
$35
*
At a glance
- Drugs Insulin aspart (Primary)
- Indications Type 1 diabetes mellitus
- Focus Pharmacodynamics
- 01 Mar 2022 Results assessing the effect of insulin on the resistance of subcutaneous tissue to the flow of infusion fluids published in the Diabetes, Obesity and Metabolism
- 26 Feb 2017 Status changed from recruiting to completed.
- 10 Mar 2016 New trial record